Intraocular Lens Market, By Product Type (Monofocal Intraocular Lens, Multifocal Intraocular Lens, Toric Intraocular Lens, and Accommodative Intraocular Lens), By Flexibility (Foldable and Rigid), By Material (Polymethylmethacrylate (PMMA), Silicone, Hydrophilic Acrylic, and Hydrophobic Acrylic), By End User (Hospitals, Ophthalmology Clinics, and Ambulatory Surgery Centers), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Feb 2025

Code : CMI690

Pages :355

Formats :

Excel and PDF

Industry : Medical Devices

Intraocular Lens Market Size and Trends

The intraocular lens market is estimated to be valued at USD 6,201.0 Mn in 2025 and is expected to reach USD 10,429.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Intraocular Lens Market Key Factors

To learn more about this report, Request sample copy

The increasing prevalence of cataracts and other eye diseases globally is boosting the market growth. According to the World Health Organization (WHO), cataract is the leading cause of blindness worldwide, affecting over 18 million people globally. Thus, the growing geriatric population who are more prone to develop cataracts, along with the rising awareness about early cataract treatment is expected to propel the demand for advanced intraocular lenses. Moreover, technological advancements in intraocular lenses such as the introduction of premium intraocular lenses and multifocal intraocular lenses are further anticipated to drive the market growth during the projected timeframe. However, the high cost associated with intraocular lenses and lack of favorable reimbursement policies in developing nations may hamper the market growth to some extent.

Increasing Inorganic Growth Strategies such as Acquisition

Increasing adoption of inorganic growth strategies, such as acquisitions by key market players, is expected to drive the market growth over the forecast period. For instance, in January 2023, Bausch Health Companies Inc., a global eye health company, announced that it had acquired AcuFocus, Inc. (“AcuFocus”), a privately-held ophthalmic medical device company, to address the diverse unmet needs in eye care. AcuFocus develops small aperture intraocular technology. Its portfolio includes the IC-8 Apthera intraocular lens (IOL).